tradingkey.logo
tradingkey.logo

BREAKINGVIEWS-Novo Nordisk is Denmark’s big little problem: podcast

ReutersMar 26, 2026 5:32 AM

By Aimee Donnellan and Jonathan Guilford

- Follow on Apple or Spotify. Listen on the Reuters app. Read the episode transcript.

Listen to the podcast

As war rages and Donald Trump looms, a recent election featured little mention of the ailing $164 bln drugmaker, once so successful it distorted economic figures. In this week’s Viewsroom, Breakingviews columnists discuss the future of weight loss pills, and Novo’s place in it.

Follow Aimee Donnellan on LinkedIn.

Follow Jonathan Guilford on X and LinkedIn.

FURTHER READING

Novo Nordisk's illness offers painful lessons

Novo Nordisk’s falling knife is still gathering speed

Obesity pills are shaky Hail Mary for Novo Nordisk

Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices to opt-out of targeted advertising.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI